Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
AN2 Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. June 3, 202690.9%
-
AN2 Therapeutics Inc. June 7, 202394.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | AN2 Therapeutics Inc. | Open-market sale | −523 | $6.02 | $3,151 |
| Sep 9, 2026 | AN2 Therapeutics Inc. | Open-market sale | −585 | $6.02 | $3,524 |
| Sep 8, 2026 | AN2 Therapeutics Inc. | Open-market sale | −4,725 | $6.02 | $28,436 |
| Sep 8, 2026 | AN2 Therapeutics Inc. | Open-market sale | −5,294 | $6.02 | $31,861 |
| Sep 3, 2026 | AN2 Therapeutics Inc. | Open-market sale | −2,877 | $6.07 | $17,463 |
| Sep 3, 2026 | AN2 Therapeutics Inc. | Open-market sale | −3,223 | $6.07 | $19,563 |
| Aug 17, 2026 | AN2 Therapeutics Inc. | Open-market sale | −16,696 | $6.01 | $100,313 |
| Aug 17, 2026 | AN2 Therapeutics Inc. | Open-market sale | −18,706 | $6.01 | $112,389 |
| Dec 19, 2024 | AN2 Therapeutics Inc. | Grant or award | +9,077 | — | — |
| Dec 10, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Dec 10, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Dec 9, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +12,289 | $1.43 | $17,573 |
| Dec 9, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +18,483 | $1.43 | $26,431 |
| Dec 6, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +12,711 | $1.45 | $18,431 |
| Dec 6, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +6,517 | $1.45 | $9,450 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.